As part of events held to mark the 10th anniversary of its pharmaceutical plant in Russia, Servier launched a new high-tech process to manufacture the medicinal products.
Speaking at the opening ceremony of this production facility, Sergey Sobyanin, the Mayor of Moscow, said, “I would like to thank the company for its high-quality products, active development of manufacturing, launch of new technologies, production of new medicines for Russia and, in particular, Moscow. I hope that you will continue to develop in the future.”
The Russian plant of Servier is actively involved in state programs aimed at the development of Russian pharmaceutical industry. Currently, 98% of the medicines are manufactured in Russia under a full-cycle production. Moreover, they are intended not only for the domestic market, but also for exports. The enterprise also acts as a reliable platform for establishing the contract manufacture. In addition, it pays a special attention to the quality of its products, as the plant participates in a pilot project on medicines labeling.
Jérôme Gavet, the Managing Director of Servier Russia & Eurasian Economic Union, said, “We view the cooperation with Russia as a priority. In 25 years of operations, we have come a long way to become one of the first European companies to transfer innovative technologies of pharmaceutical manufacturing to Russia by building a new advanced plant from scratch. This is our contribution to ensuring the national drug supply security and improving the availability of high-quality and efficient medicines for Russian citizens.”